Mexico - Delayed Quote MXN
Amgen Inc. (AMGN.MX)
5,500.00
0.00
(0.00%)
As of April 22 at 1:37:53 PM CST. Market Open.
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 1.17M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
GRAHAM JONATHAN P General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
BRADWAY ROBERT A Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
REESE DAVID M. Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
KHOSLA RACHNA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
MILLER DEREK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
GORDON MURDO Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
SANTOS ESTEBAN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
GRIFFITH PETER H. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
GRYGIEL NANCY A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
BUSCH MATTHEW C. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 3, 2025 |
REESE DAVID M. Chief Technology Officer | Sale at price 293.22 - 304.44 per share. | Direct | 10,233,748 | Feb 21, 2025 |
SANTOS ESTEBAN Officer | Conversion of Exercise of derivative security at price 156.35 per share. | Direct | 1,361,965 | Feb 19, 2025 |
REESE DAVID M. Chief Technology Officer | Conversion of Exercise of derivative security at price 156.35 per share. | Direct | 1,361,965 | Feb 19, 2025 |
MILLER DEREK Officer | Conversion of Exercise of derivative security at price 156.35 per share. | Direct | 238,277 | Feb 19, 2025 |
SANTOS ESTEBAN Officer | Sale at price 292.84 per share. | Direct | 2,550,903 | Feb 19, 2025 |
MILLER DEREK Officer | Sale at price 292.56 - 293.74 per share. | Direct | 593,934 | Feb 19, 2025 |
GORDON MURDO Officer | Sale at price 294.79 per share. | Direct | 2,585,644 | Feb 11, 2025 |
GRAHAM JONATHAN P General Counsel | Conversion of Exercise of derivative security at price 156.35 per share. | Direct | 3,915,786 | Feb 7, 2025 |
GRAHAM JONATHAN P General Counsel | Sale at price 293.12 per share. | Direct | 7,341,123 | Feb 7, 2025 |
GRYGIEL NANCY A Officer | Sale at price 304.47 per share. | Direct | 483,808 | Feb 5, 2025 |
GRAHAM JONATHAN P General Counsel | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 5, 2024 |
BRADWAY ROBERT A Chief Executive Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 2, 2024 |
HOLLEY CHARLES M JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 4, 2024 |
ISHRAK OMAR SYED Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 4, 2024 |
DRAKE MICHAEL V Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 4, 2024 |
HOLLEY CHARLES M JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 9, 2024 |
ISHRAK OMAR SYED Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 9, 2024 |
DRAKE MICHAEL V Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 9, 2024 |
KULLMAN ELLEN JAMISON Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
HOLLEY CHARLES M JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
ECKERT ROBERT ANDREW Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
MILES AMY E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
ISHRAK OMAR SYED Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
GARLAND GREGORY C. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
JACKS TYLER Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
AUSTIN WANDA M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
DRUKER BRIAN J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
DRAKE MICHAEL V Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
KLOTMAN MARY E Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 31, 2024 |
HOLLEY CHARLES M JR Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
ISHRAK OMAR SYED Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
GRAHAM JONATHAN P General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
BRADWAY ROBERT A Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
REESE DAVID M. Chief Technology Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
KHOSLA RACHNA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
MILLER DEREK Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
GORDON MURDO Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
SANTOS ESTEBAN Officer | Stock Award(Grant) at price 300.30 per share. | Direct | 899,999 | May 7, 2024 |
GRIFFITH PETER H. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
GRYGIEL NANCY A Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 7, 2024 |
Related Tickers
D4S.MU Daiichi Sankyo Co Ltd
20.55
+1.73%
4AB.F AbbVie Inc.
155.80
+0.65%
OPHLY Ono Pharmaceutical Co., Ltd.
3.8200
-2.55%
PNVL3.SA Dimed S.A. Distribuidora de Medicamentos
8.80
+1.03%
ORNBVh.XC
NOV.MU Novo Nordisk A/S
55.24
+1.47%
GRF-P.MC Grifols SA
6.41
+0.16%
0R34.IL Johnson & Johnson
155.60
-1.46%
GLAXO.BO GlaxoSmithKline Pharmaceuticals Limited
2,916.75
+2.31%
NOTA.DU Novartis AG
97.40
+0.41%